Daniel N JR Swisher

CIK 1323113 · President and COO · last filed 2026-05-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$14.65M

Companies

6

Total Filings

112

Lifetime Open-Market Net

-$4.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CORT Director 2,200 $82.91 $182.4K -$3.90M 44 2026-05-26
CERS Director 207,045 $2.56 $530.0K -$280.0K 28 2025-06-04
PTGX Director $109.78 $0 1 2023-10-30
JAZZ President and COO 60,440 $230.56 $13.94M $0 13 2023-03-07
Viracta Therapeutics, Inc. (SNSS) Delisted President and CEO 81,706 $18.62 $1.52M $134.4K 25 2017-07-12
Viracta Therapeutics, Inc. (SNSSD) Delisted President and CEO 164,510 $0 1 2011-03-02

Recent Filings · Page 11 of 12

112 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2011-11-22 Viracta Therapeutics, Inc. (SNSS) Delisted Buy (P) +2,100 $2.5K EDGAR
2011-07-18 Viracta Therapeutics, Inc. (SNSS) Delisted Buy (P) +5,000 $9.9K EDGAR
2011-07-05 Viracta Therapeutics, Inc. (SNSS) Delisted Grant (A) $0 EDGAR
2011-06-28 CERS Grant (A) $0 EDGAR
2011-03-02 Viracta Therapeutics, Inc. (SNSSD) Delisted Mixed +22,897 -$27.9K EDGAR
2010-08-03 Viracta Therapeutics, Inc. (SNSS) Delisted Mixed +52,876 -$14.9K EDGAR
2010-07-01 Viracta Therapeutics, Inc. (SNSS) Delisted Mixed +676,377 $131.0K EDGAR
2009-11-03 Viracta Therapeutics, Inc. (SNSS) Delisted Buy (P) $0 EDGAR
2009-09-02 Viracta Therapeutics, Inc. (SNSS) Delisted Grant (A) $0 EDGAR
2009-04-06 Viracta Therapeutics, Inc. (SNSS) Delisted Buy (P) $0 EDGAR
Showing 101110 of 112
Page 11 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.